Capturing nature's diversity

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Pascolutti, Mauro ^a   Campitelli, Marc ^a   Nguyen, Bao ^a   Pham, Ngoc ^a   Gorse, Alain Dominique ^a,b   Quinn, Ronald J ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NATURAL PRODUCT; BIOLOGICAL PRODUCT; MOLECULAR LIBRARY;

ARTICLE; DRUG DATABASE; DRUG STRUCTURE; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; PHARMACOPHORE; PRINCIPAL COMPONENT ANALYSIS; PROTEIN BINDING; CHEMICAL STRUCTURE; CHEMISTRY; COMBINATORIAL CHEMISTRY; DRUG DESIGN; FACTUAL DATABASE; HUMAN; MOLECULAR LIBRARY; PHARMACOLOGY;

BIOLOGICAL PRODUCTS; COMBINATORIAL CHEMISTRY TECHNIQUES; DATABASES, FACTUAL; DRUG DESIGN; HUMANS; MOLECULAR STRUCTURE; SMALL MOLECULE LIBRARIES;

EID: 84930627773     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120942     Document Type: Article

References (29)

1. Newman DJ, Cragg GM (2012) Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010. J Nat Prod 75: 311-335. doi: 10.1021/np200906s PMID: 22316239
2. Farnsworth NR, Akerele O, Bingel AS, Soejart DD, Guo Z (1985) Medicinal plants in therapy. Bull WHO 63: 965-981. PMID: 3879679
3. Feher M, Schmidt JM (2002) Property Distributions: Differences between Drugs, Natural Products, and Molecules from Combinatorial Chemistry. J Chem Inf Comput Sci 43: 218-227. PMID: 12546556
4. Grabowski K, Schneider G (2007) Properties and architecture of drugs and natural products revisited. Curr Chem Biol 1: 115-127.
5. Ganesan A (2008) The impact of natural products upon modern drug discovery. Curr Opin Chem Biol 12: 306-317. doi: 10.1016/j.cbpa.2008.03.016 PMID: 18423384
6. Wetzel S, Schuffenhauer A, Roggo S, Ertl P, Waldmann H (2007) Cheminformatic Analysis of Natural Products and their Chemical Space. CHIMIA International Journal for Chemistry 61: 355-360.
7. Hert J, Irwin JJ, Laggner C, Keiser MJ, Shoichet BK (2009) Quantifying biogenic bias in screening libraries. Nat Chem Biol 5: 479-483. doi: 10.1038/nchembio.180 PMID: 19483698
8. Hajduk PJ, Greer J (2007) A decade of fragment-based drug design: strategic advances and lessons learned. Nat Rev Drug Discov 6: 211-219. PMID: 17290284
9. Erlanson DA, McDowell RS, O'Brien T (2004) Fragment-Based Drug Discovery. J Med Chem 47: 3463-3482. PMID: 15214773
10. Murray CW, Rees DC (2009) The rise of fragment-based drug discovery. Nat Chem 1: 187-192. doi: 10.1038/nchem.217 PMID: 21378847
11. Bohacek RS, McMartin C, Guida WC (1996) The art and practice of structure-based drug design: A molecular modeling perspective. Med Res Rev 16: 3-50. PMID: 8788213
12. Over B, Wetzel S, Grütter C, Nakai Y, Renner S, Rauh D, et al. (2013) Natural-product-derived fragments for fragment-based ligand discovery. Nature Chem 5: 21-28.
13. Vu H, Roullier C, Campitelli M, Trenholme KR, Gardiner DL, Andrews KT, et al. (2013) Plasmodium Gametocyte Inhibition Identified from a Natural-Product-Based Fragment Library. ACS Chem Biol 8: 2654-2659. doi: 10.1021/cb400582b PMID: 24079418
14. Congreve M, Carr R, Murray C, Jhoti H (2003) A 'Rule of Three' for fragment-based lead discovery? Drug Discov Today 8: 876-877. PMID: 14554013
15. Congreve M, Chessari G, Tisi D, Woodhead AJ (2008) Recent Developments in Fragment-Based Drug Discovery. J Med Chem 51: 3661-3680. doi: 10.1021/jm8000373 PMID: 18457385
16. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Delivery Rev 23: 3-25.
17. McGregor MJ, Muskal SM (1999) Pharmacophore Fingerprinting. 1. Application to QSAR and Focused Library Design. J Chem Inf Comput Sci 39: 569-574. PMID: 10361729
18. Rogers D, Hahn M (2010) Extended-Connectivity Fingerprints. J Chem Inf Model 50: 742-754. doi: 10.1021/ci100050t PMID: 20426451
19. Glen RC, Bender A, Arnby CH, Carlsson L, Boyer S, Smith J (2006) Circular fingerprints: flexible molecular descriptors with applications from physical chemistry to ADME. IDrugs 9: 199-204. PMID: 16523386
20. Kohonen T (1982) Self-organized formation of topologically correct feature maps. Biol Cybern 43: 59-69.
21. Lovering F, Bikker J, Humblet C (2009) Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success. J Med Chem 52: 6752-6756. doi: 10.1021/jm901241e PMID: 19827778
22. Bemis GW, Murcko MA (1996) The Properties of Known Drugs. 1. Molecular Frameworks. J Med Chem 39: 2887-2893. PMID: 8709122
23. Chen H, Engkvist O, Blomberg N, Li J (2012) A comparative analysis of the molecular topologies for drugs, clinical candidates, natural products, human metabolites and general bioactive compounds. MedChemComm 3: 312-321. doi: 10.1101/pdb.ip068221 PMID: 22383651
24. López-Vallejo F, Giulianotti MA, Houghten RA, Medina-Franco JL (2012) Expanding the medicinally relevant chemical space with compound libraries. Drug Discov Today 17: 718-726. doi: 10.1016/j.drudis.2012.04.001 PMID: 22515962
25. Tajabadi FM, Campitelli M, Quinn RJ (2013) Scaffold Flatness: Reversing the Trend. Springer Science Reviews 1:141-151.
26. Langdon SR, Brown N, Blagg J (2011) Scaffold Diversity of Exemplified Medicinal Chemistry Space. J Chem Inf Model 51: 2174-2185. doi: 10.1021/ci2001428 PMID: 21877753
27. Tian S, Li Y, Wang J, Xu X, Xu L, Wang X, et al. (2013) Drug-likeness analysis of traditional Chinese medicines: 2. Characterization of scaffold architectures for drug-like compounds, non-drug-like compounds, and natural compounds from traditional Chinese medicines. Journal of Cheminformatics 5: 5. doi: 10.1186/1758-2946-5-5 PMID: 23336706
28. Schuffenhauer A, Ertl P, Roggo S, Wetzel S, Koch MA, Waldmann H (2006) The Scaffold Tree - Visualization of the Scaffold Universe by Hierarchical Scaffold Classification. J Chem Inf Model 47: 47-58.
29. Hung AW, Ramek A, Wang Y, Kaya T, Wilson JA, Clemons PA, et al. (2011) Route to three-dimensional fragments using diversity-oriented synthesis. Proc Natl Acad Sci 108:6799-6804. doi: 10.1073/pnas.1015271108 PMID: 21482811